These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5895001)

  • 21. Antibodies to echovirus type 30 in the Canadian population.
    Duncan IB
    Can Med Assoc J; 1968 Oct; 99(16):786-90. PubMed ID: 4176074
    [No Abstract]   [Full Text] [Related]  

  • 22. [Distribution of serum neutralizing antibodies against enterovirus in a remote area of Hokkaido].
    Fujita M; Ota I
    Iryo; 1966 Feb; 20(2):128-30. PubMed ID: 4290490
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of enterovirus in the pathogenesis of Insulin-dependent diabetes mellitus].
    Hyöty H
    Duodecim; 1996; 112(4):243-5. PubMed ID: 10590635
    [No Abstract]   [Full Text] [Related]  

  • 24. A seroepidemiological study on illnesses resembling epidemic myalgia in relation to coxsackie virus group B infection.
    Kusama T
    Fukushima J Med Sci; 1969 Aug; 16(1):1-24. PubMed ID: 5380737
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of echo 7 and 11 viruses in the population and cases of acute encephalopathy at lucknow.
    Chaturvedi UC; Mathur A; Mehrotra RM
    Indian J Pathol Bacteriol; 1972 Jan; 15(1):18-22. PubMed ID: 4642967
    [No Abstract]   [Full Text] [Related]  

  • 26. Coxsackie A 13 virus in the foci of rheumatism.
    Soboleva VD; Lozovskaya LS; Alekseveva VB; Belostotskaya NP; Bushanskaya NR; Kalinina IN
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):195-202. PubMed ID: 217930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiological background of transient hyperphosphatasemia].
    Suzuki M; Okazaki T; Asahara M; Kadohno N; Kanno T
    Rinsho Byori; 1998 Jan; 46(1):88-90. PubMed ID: 9492545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sero-epidemiologic study of myelitis following abdominal symptoms].
    Shingu M; Honda M; Kusamoto T; Nakagawa Y
    Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):454-9. PubMed ID: 4962908
    [No Abstract]   [Full Text] [Related]  

  • 29. [A serological monitoring of coxsackie B virus].
    Shi OS
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Oct; 4(5):267-9. PubMed ID: 6327042
    [No Abstract]   [Full Text] [Related]  

  • 30. [The accumulation of antihemagglutinating and virus neutralizing antibodies to ECHO viruses].
    Savchenko BI; Gubenko TL
    Mikrobiol Zh; 1972; 34(1):52-4. PubMed ID: 5077259
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence and titres of neutralising antibodies to group B coxsackieviruses.
    Mukundan P; John TJ
    Indian J Med Res; 1983 May; 77():577-89. PubMed ID: 6311734
    [No Abstract]   [Full Text] [Related]  

  • 32. Various antibodies holding status against viruses in Cercopithecus aethiops and Macaca irus. IV. The presence of antibodies against viruses of human and simian origin.
    Owada Y; Yamane Y; Nagashima T; Takada M; Asahara T
    Kitasato Arch Exp Med; 1969 Jun; 42(1):41-57. PubMed ID: 4321641
    [No Abstract]   [Full Text] [Related]  

  • 33. Study on enterovirus 70: age distribution of neutralizing antibody and some characteristics of the virus.
    Lin KH; Chiang CH; Yang CS
    Taiwan Yi Xue Hui Za Zhi; 1985 Mar; 84(3):296-307. PubMed ID: 2991419
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cuban epidemic neuropathy. III. Neutralizing antibodies to the strains isolated and to other enteroviruses in patients and healthy subjects].
    Más Lago P; Balmaseda A; Avalos I; Castillo A; Guzmán MG; Llop A; Palomera R
    Rev Cubana Med Trop; 1995; 47(1):21-5. PubMed ID: 9805062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxsackie B virus infection and myopericarditis in Thailand, 1987-1989.
    Dechkum N; Pangsawan Y; Jayavasu C; Saguanwongse S
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):273-6. PubMed ID: 9886111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and laboratory findings in an epidemic of type 9 ECHO virus meningitis in the Tokushima area, Japan.
    Miyao M; Hamada Y; Okamoto T; Hayashi K; Kokawa I
    Tokushima J Exp Med; 1969 Jun; 16(1):21-5. PubMed ID: 4981561
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coxsackie viruses and diabetes mellitus].
    Cihula J; Horácek J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1978; 21(5):499-506. PubMed ID: 228385
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of the antigenic components of Coxsackie and ECHO viruses and their antibodies].
    Schmidt WA
    Arch Gesamte Virusforsch; 1971; 33(1):77-87. PubMed ID: 4325978
    [No Abstract]   [Full Text] [Related]  

  • 39. Various antibody holding status against viruses in Cercopithecus aethiops and Macaca irus. II. The presence of neutralizing antibody against herpes virus, ECHO virus and simian virus 40.
    Nagashima T; Takada M; Yamane Y; Owada Y; Kasahara S
    Kitasato Arch Exp Med; 1967 Dec; 40(1):45-56. PubMed ID: 4303328
    [No Abstract]   [Full Text] [Related]  

  • 40. Echovirus 11 infections of newborns with mortality during the 1979 enterovirus season in Milwaukee, Wis.
    Piraino FF; Sedmak G; Raab K
    Public Health Rep; 1982; 97(4):346-53. PubMed ID: 6287514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.